series-a
Stage
2
Investors
About
advanceCOR GmbH is a clinical-stage biopharmaceutical company focused on developing novel therapeutic approaches for acute and chronic cardiovascular diseases. Their lead candidate is a small molecule inhibitor designed to target pathways involved in cardiac damage.
Explore advanceCOR GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.